Safety Study of Viaskin Peanut to Treat Peanut Allergy
NCT02916446
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
393
Enrollment
INDUSTRY
Sponsor class
Conditions
Peanut Allergy
Interventions
BIOLOGICAL:
Viaskin Peanut 250 mcg
BIOLOGICAL:
Placebo
Sponsor
DBV Technologies